Increase Productivity, Improve Patient Care and Retain a Collaborative, High-quality Workforce

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

whitePaper | September 23, 2022

Many of the largest healthcare organizations rely on the mainframe to run their businesses and safeguard a wealth of sensitive data, from patient records to billing information, but why is the mainframe the platform of choice for so many?

whitePaper | August 25, 2022

As the market enters the post-pandemic era, payers and providers are tasked with providing a customer and employee experience that keeps pace with that offered by a new wave of digital-native challengers.

whitePaper | January 13, 2020

Today, healthcare organizations are witnessing a major shift in power. The industry is realigning itself increasingly around the priorities of patients. The change is unstoppable — and healthcare companies must act swiftly to avoid getting left behind.

whitePaper | December 7, 2022

The target market for conducting global clinical trials has changed significantly, moving beyond pharmaceutical early adopters to the mainstream marketplace.

whitePaper | August 25, 2022

The revenue cycle process has a long and cumbersome history that continues to become more complex as policies, payer relationships, and patient expectations evolve.